Nebraska’s voter-created Medical Cannabis Commission continued developing licensing fees and regulations in 2026, and the state approved its first cultivation activity under the emerging system. The central dispute is whether regulators are moving cautiously enough to protect patients and public safety or imposing rules that make the voter-approved program too limited, costly, or slow to function. A vertically integrated cannabis license allows one business to perform multiple stages such as cultivation, processing, distribution, or dispensing. Patients voted for access, not just a commission and paperwork. Regulation should control product safety and diversion without making legal medicine practically unavailable.
What would count as faithful implementation of Nebraska’s medical-cannabis vote?